AstraZeneca puts $2 billion into Summit Therapeutics
AstraZeneca agreed to invest $2 billion in Summit Therapeutics on Monday, sending the biotech’s shares up as much as 19 percent in after-hours trading
Akeso
Every Fin-node story mentioning Akeso — 1 story, newest first.
Akeso · 1 story